The WNBA Just Dropped Marijuana Testing: What It Means for Cannabis in Professional Sports

Buried in item number 31 of a 37-point proposal slide during collective bargaining negotiations, five words quietly closed a chapter in professional sports history: "Elimination of Marijuana Testing."

The Women's National Basketball Association has agreed in principle to stop testing its players for marijuana as part of a new seven-year collective bargaining agreement running through 2032. The provision, confirmed by the WNBA Board of Governors in its ratification of the new CBA terms, makes the league the latest — and arguably the last significant holdout — among major American professional sports organizations to abandon cannabis prohibition for its athletes.

It's a move that tells us more about where American culture is headed than any policy paper or poll could.

What Changed

Under the previous CBA, WNBA players were subject to marijuana testing as part of the league's substance abuse program. A positive test could result in fines, mandatory counseling, and suspension — consequences that players and their union had increasingly viewed as outdated, punitive, and out of step with both the science of cannabis and the legal reality in the majority of states where WNBA teams play.

The new agreement removes marijuana from the list of banned substances entirely. Players will still be subject to testing for performance-enhancing drugs and other prohibited substances, but cannabis — whether used medicinally, recreationally, or for recovery — will no longer trigger any league consequence.

The change didn't happen in isolation. It was one piece of a comprehensive CBA negotiation that also addressed player salaries, housing provisions, revenue sharing, and other quality-of-life improvements. But its inclusion in the agreement reflects something the players' union had been pushing for years: the recognition that policing cannabis use is not a legitimate function of a sports league in 2026.

The Domino Effect Across Professional Sports

The WNBA's decision follows a remarkably consistent pattern across American professional sports — a pattern that accelerated dramatically after 2020.

The NBA effectively stopped testing players for marijuana during the COVID-19 pandemic and never resumed random testing for cannabis. While the league technically retains the ability to test for "reasonable cause," the practical reality is that NBA players have been free to use cannabis without league consequences for years.

The NFL, historically one of the most aggressive leagues in policing cannabis use, overhauled its substance abuse policy in the 2020 CBA. The revised policy raised the THC threshold for a positive test to 150 nanograms per milliliter — up from 35 — effectively making it nearly impossible to fail a marijuana test. The league also eliminated suspensions for positive cannabis tests and narrowed its testing window.

Major League Baseball removed marijuana from its banned substances list in 2019, making it the first major professional league to do so formally. The decision came after the tragic death of pitcher Tyler Skaggs and a broader reckoning with how the league approached substance use.

The NHL never included marijuana on its banned substances list, though positive tests could trigger intervention protocols. In practice, hockey has been the most permissive major league regarding cannabis for decades.

MLS followed a similar trajectory, relaxing its cannabis policies in the early 2020s and effectively removing marijuana testing from its anti-doping program.

What's striking about this timeline is how compressed it is. In 2019, multiple leagues were still suspending athletes for cannabis use. By 2026, none are. The shift happened faster than almost anyone predicted, driven by a convergence of player advocacy, changing public attitudes, and the recognition that cannabis penalties were creating more problems than they solved.

The Player Perspective

For WNBA players specifically, the elimination of marijuana testing addresses several practical realities that the league's previous policy ignored.

Recovery is paramount. Professional basketball is physically brutal — the travel, the games, the practices, the off-season training create a relentless cycle of physical stress and recovery. Many athletes across all sports have spoken publicly about using cannabis for pain management, sleep quality, and inflammation reduction as alternatives to prescription opioids and NSAIDs.

Brittney Griner's 2022 detention in Russia — where she was arrested for possessing cannabis vape cartridges — brought intense public attention to the reality that WNBA players use cannabis. The incident highlighted the absurdity of a system that treated cannabis as a moral failing while players routinely traveled to countries with far more punitive drug laws.

Mental health is increasingly part of the conversation as well. WNBA players, like athletes across all sports, face intense performance pressure, public scrutiny, and the physical toll of a professional career. For players who find cannabis helpful for anxiety, sleep, or general well-being, the elimination of testing removes a source of stress and stigma.

What It Doesn't Change

The CBA provision eliminates league-level testing and consequences, but it doesn't create a free-for-all. Several constraints remain.

Anti-doping rules from the World Anti-Doping Agency (WADA) still prohibit cannabis use in competition for athletes subject to international testing — meaning WNBA players competing in the Olympics or other FIBA events may still face cannabis restrictions at those competitions, regardless of the league's domestic policy.

Team-level conduct policies could theoretically still address cannabis use in specific contexts — for example, showing up to a game or practice visibly impaired. The CBA addresses testing, not behavior standards more broadly.

And the legal landscape, while overwhelmingly trending toward legalization, still includes states where recreational cannabis is illegal. Players in those markets technically remain subject to state law, though the practical likelihood of prosecution for personal use is vanishingly small.

The Cultural Shift in Numbers

The WNBA's move reflects a broader cultural shift that the numbers make unavoidable. Sixty-eight percent of Americans support full cannabis legalization. Thirty-eight states have legalized some form of cannabis. The federal government just reclassified medical marijuana to Schedule III. Cannabis is a $38.5 billion industry that employs hundreds of thousands of people.

In this context, testing professional athletes for a substance that is legal in the majority of the country, used by roughly 50 million Americans, and increasingly recommended by sports medicine professionals for recovery and pain management had become an exercise in institutional inertia rather than a defensible policy position.

The leagues that moved first — MLB, the NBA, the NFL — did so tentatively, with raised thresholds and narrowed testing windows rather than outright elimination. The WNBA, arriving later, was able to go further: full elimination, no hedging, no asterisks.

Sponsorship and the Business Angle

There's a commercial dimension to the WNBA's decision that shouldn't be overlooked. The cannabis industry has been eager to partner with professional sports leagues, and the elimination of marijuana testing removes a significant reputational barrier.

Cannabis brands have already become visible sponsors in the NFL, NBA, and MLS. The WNBA, which has been aggressively pursuing new revenue streams and commercial partnerships as the league grows, is now positioned to explore cannabis-related sponsorships without the optics of simultaneously punishing players for using the sponsor's product category.

It's a small but meaningful alignment of incentives: the league can't credibly pursue cannabis sponsorship dollars while testing players for cannabis. Eliminating the testing removes the contradiction.

Looking Forward

The WNBA's decision to drop marijuana testing is, in the grand scheme of things, a footnote. It's one item in a 37-point CBA proposal for a league that is still growing into its cultural and commercial potential.

But footnotes can be revealing. When the last major professional sports league in America decides that testing its athletes for cannabis is no longer worth the effort, the contradiction, or the conversation — that's not just a labor negotiation outcome. It's a cultural verdict.

The debate over cannabis in professional sports is, for all practical purposes, over. The athletes won. The science won. The culture moved on. And the scoreboard reads: Cannabis 1, Prohibition 0.

Wherever you stand on the cannabis-and-sports debate, you can find a dispensary near you on Budpedia in any of the 38 states where adult use or medical access is legal.